1-20 of 46
Celina Ledesma
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Allogeneic Hematopoietic Stem Cell Transplantation in Adolescents and Young Adults with Acute Lymphoblastic Leukemia - Retrospective Dual-Center Study

Oren Pasvolsky, Shai Shimony, Rima M. Saliba, Celina Ledesma, Gabriela Rondon, Priti Tewari, Dristhi Ragoonanan, Nicholas J. Short, Elias Jabbour, Mahasweta Gooptu, Vincent T. Ho, Robert J. Soiffer, Joseph Antin, John Koreth, Corey Cutler, Jonathan Paolino, Christine Duncan, Leslie E. Lehmann, Daniel J. DeAngelo, Hagop M. Kantarjian, Richard E. Champlin, Elizabeth J. Shpall, Marlise R. Luskin, Partow Kebriaei
Journal: Blood
Blood (2023) 142 (Supplement 1): 4979.
https://doi.org/10.1182/blood-2023-179962
Published: 2023
Journal Articles

A Multicenter Analysis of Allogeneic Transplant Outcomes in Patients with Philadelphia-like (Ph-like) Acute Lymphoblastic Leukemia (ALL)

Zaid Abdel Rahman, Paul B. Koller, Tamer Othman, Rima M. Saliba, Yenny Alejandra Moreno Vanegas, Razan Mohty, Celina Ledesma, Gabriela Rondon, Nitin Jain, Elias Jabbour, Vinod Pullarkat, Hassan Alkhateeb, Hagop M. Kantarjian, Patricia Greipp, Ryotaro Nakamura, Mohamed A. Kharfan-Dabaja, Richard E. Champlin, Stephen J. Forman, Elizabeth J. Shpall, Mark R. Litzow, James M. Foran, Ibrahim Aldoss, Partow Kebriaei
Journal: Blood
Blood (2023) 142 (Supplement 1): 656.
https://doi.org/10.1182/blood-2023-178150
Published: 2023
Journal Articles

Allogeneic Transplant for CLL Richter's Transformation: Single Center Retrospective Analysis

Alejandro Marinos Velarde, Rima M. Saliba, Celina Ledesma, Elizabeth J. Shpall, Muzaffar H. Qazilbash, Uday R. Popat, Qaiser Bashir, Yago Nieto, David Marin, Betul Oran, Amanda L. Olson, Samer A. Srour, Amin Alousi, Jeremy Ramdial, Partow Kebriaei, Alessandra Ferrajoli, William G. Wierda, Richard E. Champlin, Chitra Hosing
Journal: Blood
Blood (2023) 142 (Supplement 1): 7086.
https://doi.org/10.1182/blood-2023-173194
Published: 2023
Journal Articles

Prognostic Significance of Measurable Residual Disease for Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Stem Cell Transplant in Second Complete Remission and Beyond

Oren Pasvolsky, Rima M. Saliba, Celina Ledesma, Uday R Popat, Amin M Alousi, Amanda L. Olson, Betul Oran, Chitra Hosing, Qaiser Bashir, Muzaffar H Qazilbash, Nicholas Short, Farhad Ravandi, Richard E Champlin, Elizabeth J Shpall, Partow Kebriaei
Journal: Blood
Blood (2022) 140 (Supplement 1): 7695–7696.
https://doi.org/10.1182/blood-2022-155916
Published: 2022
Journal Articles

High Efficacy of the PARP Inhibitor Olaparib Combined with High-Dose Chemotherapy and Autologous Stem-Cell Transplant for Refractory Lymphomas

Yago Nieto, Benigno C Valdez, Peter F Thall, Jeremy L. Ramdial, Samer A Srour, Chitra Hosing, Neeraj Saini, Amin M Alousi, Muzaffar H Qazilbash, Uday R Popat, Alison Gulbis, Terri Lynn Shigle, Roland Bassett, Maria Guillermo-Pacheco, Celina Ledesma, Paolo Strati, Sairah Ahmed, Raphael Steiner, Jason Westin, Ranjit Nair, Swaminathan P. Iyer, Richard E Champlin, Elizabeth J Shpall, Borje S Andersson
Journal: Blood
Blood (2022) 140 (Supplement 1): 1183–1184.
https://doi.org/10.1182/blood-2022-156121
Published: 2022
Journal Articles

Allogeneic and Autologous Hematopoietic Transplants Can be Safely Performed after COVID-19 Infections

Jeremy L. Ramdial, Rima M. Saliba, Amin M. Alousi, Gabriela Rondon, Julianne Chen, Celina Ledesma, Elizabeth J. Shpall, Roy Chemaly, Richard E. Champlin
Journal: Blood
Blood (2021) 138 (Supplement 1): 2855.
https://doi.org/10.1182/blood-2021-153997
Published: 2021
Journal Articles

Maintenance Therapy with Ipilimumab Plus Lenalidomide after Autologous Stem Cell Transplantation for Patients with Lymphoma

Issa F. Khouri, MD, Denái R. Milton, MS, Celina Ledesma, Elias Jabbour, MD, Qaiser Bashir, Jin S. Im, Luis Fayad, Hun Ju Lee, MD, Ranjit Nair, Loretta J. Nastoupil, MD, Felipe Samaniego, MD, Swami P. Iyer, MD, Christopher Flowers, MDMS, Richard E. Champlin, MD, Padmanee Sharma, Alison Gulbis
Journal: Blood
Blood (2020) 136 (Supplement 1): 9–11.
https://doi.org/10.1182/blood-2020-138778
Published: 2020
Journal Articles

Nonmyeloablative Allogeneic Stem Cell Transplantation with or without Inotuzumab Ozogamicin for Lymphoid Malignancies

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Alison Gulbis, Celina Ledesma, Nitin Jain, MD, Tapan M. Kadia, MD, Naveen Pemmaraju, MD, Paolo Anderlini, Qaiser Bashir, MD, May Daher, Partow Kebriaei, MD, David Marin, Rohtesh Mehta, Uday R. Popat, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Jin S. Im, Luis Fayad, Ranjit Nair, MD, Swaminathan P Iyer, MD, Paolo Strati, MD, Felipe Samaniego, MD, Loretta J. Nastoupil, MD, Christopher Flowers, MDMS, Gabriela Rondon, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Elias Jabbour, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 10–12.
https://doi.org/10.1182/blood-2020-141985
Published: 2020
Journal Articles

Autologous Vs. Allogeneic Stem Cell Transplantation in Double-Expressor Lymphoma

Issa F. Khouri, MD, Stephen K. Gruschkus, PhD MPH, Celina Ledesma, Paolo Anderlini, Qaiser Bashir, May Daher, Swami P. Iyer, MD, David Marin, Rohtesh Mehta, Amanda L. Olson, Uday R. Popat, MD, Felipe Samaniego, MD, Muzaffar H. Qazilbash, MD, Jin S. Im, Gabriela Rondon, Richard E. Champlin, MD, Alison Gulbis, Ken H. Young
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-138741
Published: 2020
Journal Articles

Risk of Gvhd and Survival in Patients with Acute Leukemia Who Were Bridged to Allogeneic Stem Cell Transplantation (alloSCT) with Venetoclax- Based Therapy

Akash Mukherjee, Denái R. Milton, MS, Elias Jabbour, MD, Naval Daver, MD, Alison Gulbis, Celina Ledesma, Marina Konopleva, MD PhD, Courtney D. DiNardo, MD MSCE, Farhad Ravandi, MBBS, Tapan M. Kadia, MD, Gheath Alatrash, Amin M. Alousi, MD, May Daher, David Marin, Amanda L. Olson, Betul Oran, MDMS, Partow Kebriaei, MD, Neeraj Saini, MD, Samer A. Srour, MD MS, Uday R. Popat, MD, Jin S. Im, Rohtesh Mehta, Gabriela Rondon, Hagop M. Kantarjian, MD, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 13–14.
https://doi.org/10.1182/blood-2020-137097
Published: 2020
Journal Articles

Impact of TKIs post–allogeneic hematopoietic cell transplantation in Philadelphia chromosome–positive ALL

Clinical Trials & Observations
Neeraj Saini, David Marin, Celina Ledesma, Ruby Delgado, Gabriela Rondon, Uday R. Popat, Qaiser Bashir, Chitra M. Hosing, Yago Nieto, Amin M. Alousi, Muzaffar H. Qazilbash, Stefan Ciurea, Elizabeth Shpall, Issa Khouri, Hagop Kantarjian, Elias Jabbour, Farhad Ravandi, Richard E. Champlin, Partow Kebriaei
Journal: Blood
Blood (2020) 136 (15): 1786–1789.
https://doi.org/10.1182/blood.2019004685
Published: 2020
Includes: Supplemental data
Journal Articles

Clinical Relevance of MYC/BCL2 and Cell of Origin in Patients with Relapsed Diffuse Large B-Cell Lymphoma Treated with Autologous Stem Cell Transplantation

Yingjun Wang, Ken H. Young, MD PhD, Denái R. Milton, Celina Ledesma, Elias Jabbour, MD, Zijun Yidan Xu-Monette, PhD, Jeffrey J. Molldrem, Paolo Anderlini, Amin M. Alousi, MD, Qaiser Bashir, MBBS, May Daher, MD, Luis E. Fayad, MD, Swaminathan P. Iyer, MD, Partow Kebriaei, MD, David Marin, MD, Rohtesh S. Mehta, MD, Amanda L. Olson, MD, Uday Popat, MD, Felipe Samaniego, MD, Jason R. Westin, MD, Muzaffar H. Qazilbash, MD, Jin S Im, MD PhD, Gabriela Rondon, MD, Alison Gulbis, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2021.
https://doi.org/10.1182/blood-2019-126719
Published: 2019
Journal Articles

Nonmyeloablative Allogeneic Transplantation (NMAT) Confers an Overall Survival Benefit with Similar Non-Relapse Mortality When Compared to Autologous Stem Transplantation (ASCT) for Patients (pts) with Relapsed Follicular Lymphoma (FL)

Issa F. Khouri, MD, Denái R. Milton, Celina Ledesma, Loretta J. Nastoupil, MD MSc, Elias Jabbour, MD, Paolo Anderlini, Qaiser Bashir, MBBS, Stefan O. Ciurea, MD, May Daher, MD, Luis E. Fayad, MD, Jin S Im, MD PhD, Swaminathan P. Iyer, MD, David Marin, MD, Rohtesh S. Mehta, MD, Jeffrey J. Molldrem, Amanda L. Olson, MD, Betul Oran, MDMS, Uday Popat, MD, Muzaffar Qazilbash, Samer Srour, Felipe Samaniego, MD, Gabriela Rondon, MD, L. Jeffrey Medeiros, MD, Alison Gulbis, Richard E Champlin
Journal: Blood
Blood (2019) 134 (Supplement_1): 322.
https://doi.org/10.1182/blood-2019-124590
Published: 2019
Journal Articles

Post-Transplant Cyclophosphamide (PT-Cy) Based Haploidentical Cell Transplantation (Haplo) Versus Rabbit Anti-Thymocyte Globulin (r-ATG) Based HLA Matched Unrelated Donor (MUD) Transplantation in Patients (pts) with Relapsed/Refractory Lymphoma

Akash Mukherjee, MD, Denái R. Milton, Alison Gulbis, Celina Ledesma, Elias Jabbour, MD, Amin M. Alousi, MD, Qaiser Bashir, MBBS, May Daher, MD, Betul Oran, MDMS, Amanda L. Olson, MD, David Marin, MD, Samer Srour, Partow Kebriaei, MD, Rohtesh S. Mehta, MD, Kathie P Nemeth, BS, Uday Popat, MD, Jin S Im, MD PhD, Richard E. Champlin, MD, Issa F. Khouri, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4530.
https://doi.org/10.1182/blood-2019-125876
Published: 2019
Journal Articles

Allogeneic Hematopoietic Cell Transplantation May Improve Long-Term Outcomes in Patients with Ph-like Acute Lymphoblastic Leukemia with CRLF2 Overexpression

Paul Koller, Rima M. Saliba, PhD, Celina Ledesma, Gabriela Rondon, MD, Uday Popat, MD, Amin M. Alousi, MD, Rohtesh S. Mehta, MD, Betul Oran, MDMS, Amanda L. Olson, MD, Chitra Hosing, MD, Muzaffar H. Qazilbash, MD, Issa F. Khouri, MD, Stefan O. Ciurea, MD, Elizabeth J. Shpall, MD, Jeffrey L. Jorgensen, MD PhD, Sa A Wang, MD, Nitin Jain, MD, Elias Jabbour, MD, Hagop M. Kantarjian, MD, Richard E Champlin, Marina Y Konopleva, MD PhD, Partow Kebriaei, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4598.
https://doi.org/10.1182/blood-2019-130645
Published: 2019
Journal Articles

Influence of the Intensity of the Conditioning Regimens on the Risks of Gvhd in Patients Receiving Rituximab Prophylaxis during Allogeneic Stem Cell Transplantation (alloSCT)

Issa F. Khouri, Denái R. Milton, Celina Ledesma, Elias J. Jabbour, MD, Gheath Alatrash, DO, PhD, Paolo Anderlini, MD, Amin M. Alousi, MD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Sharon Hymes, BS, MD, David Marin, MD, Jeffrey J. Molldrem, MD, Amanda L. Olson, MD, Betul Oran, MDMS, Uday Popat, MD, Muzaffar H. Qazilbash, MD, Gabriela Rondon, MD, Richard E Champlin, MD, Alison Gulbis
Journal: Blood
Blood (2018) 132 (Supplement 1): 4584.
https://doi.org/10.1182/blood-2018-99-112990
Published: 2018
Journal Articles

Durability Results of Non-Myeloablative (NMA) Allogeneic Stem Cell Transplantation (alloSCT) for Relapsed Follicular Lymphoma: 17- Year Experience

Issa F. Khouri, Denái R. Milton, Celina Ledesma, William D Erwin, MS, Elias J. Jabbour, MD, Gheath Alatrash, DO, PhD, Paolo Anderlini, MD, Qaiser Bashir, MD MBBS, Stefan O. Ciurea, Jin S Im, MD PhD, David Marin, MD, Rohtesh S. Mehta, MD MPH, MS, Jeffrey J. Molldrem, MD, Amanda L. Olson, MD, Betul Oran, MD MS, Uday Popat, MD, Muzaffar H. Qazilbash, MD, Gabriela Rondon, MD, Richard E Champlin, MD, L. Jeffrey Medeiros, MD, Alison Gulbis
Journal: Blood
Blood (2018) 132 (Supplement 1): 4651.
https://doi.org/10.1182/blood-2018-99-117767
Published: 2018
Journal Articles

Safety of Addition of Inotuzumab Ozogamicin (CMC 544) to Bendamustine, Fludarabine, and Rituximab (BFR) Allogeneic Conditioning for Lymphoid Malignancies

Issa F. Khouri, Alison M. Gulbis, Denái R. Milton, Martin Korbling, MD, Celina Ledesma, Sairah Ahmed, Amin M. Alousi, MD, Betul Oran, MDMS, Paolo Anderlini, Stefan O. Ciurea, Roland L. Bassett, Jr., Elias J. Jabbour, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3240.
https://doi.org/10.1182/blood.V130.Suppl_1.3240.3240
Published: 2017
Journal Articles

Early Maintenance with Tyrosine Kinase Inhibitors Post Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) Improves Survival in Ph+ Acute Lymphoblastic Leukemia (ALL) Patients

Lohith Gowda, MD, Majdi Alijadayeh, MD, David Costa Marin, MD, Celina Ledesma, Gabriela Rondon, MD, Uday Popat, MD, Amin M. Alousi, Betul Oran, MDMS, Mithun Vinod Shah, MD PhD, Sairah Ahmed, MD, Rashmi Kanagal-Shamanna, MD, Stefan O. Ciurea, Elizabeth J Shpall, MD, Raja Luthra, Chitra Hosing, MD, Muzaffar H. Qazilbash, MD, Katy Rezvani, MD PhD, Elias J. Jabbour, MD, Keyur P. Patel, MBBS, PhD, Farhad Ravandi, MBBS, Hagop M. Kantarjian, MD, Richard E Champlin, MD, Partow Kebriaei, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1992.
https://doi.org/10.1182/blood.V130.Suppl_1.1992.1992
Published: 2017
Journal Articles

Bfr (bendamustine, fludarabine, rituximab) Nonmyeloablative Allogeneic Conditioning for Lymphoid Malignancies: 8-Year Results

Issa F. Khouri, Elias J. Jabbour, MD, Celina Ledesma, Martin Korbling, MD, Amin M. Alousi, Paolo Anderlini, Betul Oran, MDMS, Stefan O. Ciurea, Luis E. Fayad, Roland L. Bassett, Jr., Alison M. Gulbis
Journal: Blood
Blood (2017) 130 (Supplement 1): 2036.
https://doi.org/10.1182/blood.V130.Suppl_1.2036.2036
Published: 2017